Concepedia
Statistics
Publications
7
Citations
181
H-Index
Active since
2018
Affiliations
Humanitas University(Current)
IRCCS Humanitas Research Hospital
Istituti di Ricovero e Cura a Carattere Scientifico
University of Milan
University of Chicago
Nadia Cordua is an author at Humanitas University specializing in medicine, oncology, and pharmacology.
Publications per year
2018–2024
Avelumab plus axitinib in unresectable or metastatic type B3 thymomas and thymic carcinomas (CAVEATT): a single-arm, multicentre, phase 2 trial
Fabio Conforti, Paolo Andrea Zucali, Laura Pala et al. · The Lancet Oncology · 2022 · 59 citations
Medicine, Oncology, Pharmacology +12
Efficacy and safety of ramucirumab plus carboplatin and paclitaxel in untreated metastatic thymic carcinoma: RELEVENT phase II trial (NCT03921671)
Claudia Proto, M. Ganzinelli, Sara Manglaviti et al. · Annals of Oncology · 2024 · 31 citations · Full text
Medicine, Oncology, Pharmacology +14
STYLE (NCT03449173): A Phase 2 Trial of Sunitinib in Patients With Type B3 Thymoma or Thymic Carcinoma in Second and Further Lines
Claudia Proto, Sara Manglaviti, Giuseppe Lo Russo et al. · Journal of Thoracic Oncology · 2023 · 27 citations · Full text
Medicine, Oncology, Pharmacotherapy +6
Resound Trial: A phase 2 study of regorafenib in patients with thymoma (type B2‐B3) and thymic carcinoma previously treated with chemotherapy
Matteo Perrino, Tommaso De Pas, Silvia Bozzarelli et al. · Cancer · 2021 · 23 citations · Full text
Medicine, Oncology, Pharmacology +16
Prognostic Significance of Organ-Specific Metastases in Patients with Metastatic Upper Tract Urothelial Carcinoma
Antonio Tufano, Nadia Cordua, Valerio Nardone et al. · Journal of Clinical Medicine · 2022 · 17 citations · Full text
Medicine, Biostatistics, Oncology +14
1–5 of 7